Accelerated functional brain aging in major depressive disorder: evidence from a large scale fMRI analysis of Chinese participants

@article{Luo2022AcceleratedFB,
  title={Accelerated functional brain aging in major depressive disorder: evidence from a large scale fMRI analysis of Chinese participants},
  author={Yu Luo and Wen-Xiu Chen and Jiang Qiu and Tao Jia},
  journal={ArXiv},
  year={2022},
  volume={abs/2205.04871}
}
Major depressive disorder (MDD) is one of the most common mental health conditions that has been intensively investigated for its association with brain atrophy and mortality. Recent studies reveal that the deviation between the predicted and the chronological age can be a marker of accelerated brain aging to characterize MDD. However, current conclusions are usually drawn based on structural MRI information collected from Caucasian participants. The universality of this biomarker needs to be… 

Figures and Tables from this paper

References

SHOWING 1-10 OF 86 REFERENCES
Accelerated aging of the putamen in patients with major depressive disorder
TLDR
The results indicate that putamen aging is accelerated in patients with MDD, which may uniquely contribute to the adverse long-term effects of depressive psychopathology and may be a useful target for the treatment of MDD across the lifespan.
Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group
TLDR
This highly powered collaborative effort showed subtle patterns of age-related structural brain abnormalities in MDD, and substantial within-group variance and overlap between groups were observed.
Accelerated brain aging predicts impulsivity and symptom severity in depression
TLDR
The results indicate that MDD is associated with accelerated brain aging, and that accelerated aging is selectively associated with greater impulsivity and depression severity.
Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group
TLDR
Three-dimensional brain magnetic resonance imaging data was meta-analyzed to identify subcortical brain volumes that robustly discriminate major depressive disorder patients from healthy controls and showed robust smaller hippocampal volumes in MDD patients, moderated by age of onset and first episode versus recurrent episode status.
Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
TLDR
Application of the predictive model to the context of pre-clinical AD revealed that the pre-symptomatic phase of autosomal dominant AD includes acceleration of functional brain aging, and this association was stronger in individuals having significant Aβ pathology.
Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group
TLDR
This highly powered global effort to identify consistent brain abnormalities showed widespread cortical alterations in MDD patients as compared to controls and suggests that MDD may impact brain structure in a highly dynamic way, with different patterns of alterations at different stages of life.
Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls
TLDR
Differences in brain circuitry are present from illness onset most prominently in schizophrenia and to a lesser extent in BD, and support a non-progressive “early hit” hypothesis/etiology of illness in the major psychoses.
The stage‐specifically accelerated brain aging in never‐treated first‐episode patients with depression
TLDR
The results reveal that accelerated brain aging occurs at illness onset and suggest it is a stage‐dependent phenomenon in depression.
Accelerated Brain Aging in Schizophrenia: A Longitudinal Pattern Recognition Study.
TLDR
The progressive brain loss in schizophrenia appears to reflect two different processes: one relatively homogeneous, reflecting accelerated aging of the brain and related to various measures of outcome, and a more variable one, possibly reflecting individual variation and medication use.
...
...